Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
PTS-500 by Gongwin Biopharm for Non-Small Cell Lung Cancer: Likelihood of Approval
PTS-500 is under clinical development by Gongwin Biopharm and currently in Phase II for Non-Small Cell Lung Cancer. According to...
PTS-500 by Gongwin Biopharm for Malignant Pleural Effusion: Likelihood of Approval
PTS-500 is under clinical development by Gongwin Biopharm and currently in Phase II for Malignant Pleural Effusion. According to GlobalData,...
PTS-100 by Gongwin Biopharm for Hepatocellular Carcinoma: Likelihood of Approval
PTS-100 is under clinical development by Gongwin Biopharm and currently in Phase II for Hepatocellular Carcinoma. According to GlobalData, Phase...
PTS-500 by Gongwin Biopharm for Squamous Non-Small Cell Lung Cancer: Likelihood of Approval
PTS-500 is under clinical development by Gongwin Biopharm and currently in Phase II for Squamous Non-Small Cell Lung Cancer. According...